GXPS vs IYK

Key Takeaways

• GXPS and IYK both target U.S. consumer staples, but they are structured differently: GXPS is an uncapped, pure-play index fund, while IYK applies capped weightings and blends in modest healthcare and materials exposure.
• Cost structure diverges sharply. GXPS carries a net expense ratio of about 0.15%, roughly half the level of IYK's approximate 0.38% fee, giving GXPS a structural cost advantage over time.
• Concentration differs meaningfully. GXPS holds roughly 31 names with its top 10 near 80% of assets, whereas IYK holds roughly 54–58 names with a top 10 closer to 66%, favoring IYK for broader diversification.
• Positioning tilts toward megacap leaders. GXPS is heavily weighted to Walmart and Costco, while IYK leans on Procter & Gamble, Coca-Cola, and Philip Morris International.
• Risk profiles vary. IYK is a mature, liquid, lower-beta fund with a long track record, while GXPS is a newer, smaller fund with less liquidity but purer sector exposure.
• Tickeron AI Verdict: On balance, Tickeron's AI favors GXPS for its lower cost and concentrated exposure to the sector's stronger momentum names, with the caveat of its smaller asset base.

Introduction

Consumer staples are a cornerstone of defensive equity allocation, and two funds offer very different ways to access the same pocket of the market. GXPS and IYK are not direct clones: GXPS is a recently launched, uncapped pure-play on the MSCI USA Consumer Staples Index, while IYK is a long-established iShares fund that tracks a capped consumer staples benchmark and quietly blends in healthcare and materials names. This ETF comparison matters right now because investors weighing sector exposure, relative positioning, and cost efficiency are increasingly scrutinizing how concentration and fee drag shape fund performance over full market cycles.

Global X PureCap MSCI Consumer Staples ETF (GXPS) Overview

GXPS is a passively managed fund that seeks to track the MSCI USA Consumer Staples Index, which classifies U.S.-listed companies using the Global Industry Classification Standard (GICS). Its defining feature is an uncapped, free-float market-capitalization methodology: the index does not impose company-level weighting limits, allowing the sector's largest names to dominate. The fund uses representative sampling and is non-diversified.

GXPS holds roughly 31 securities, with its top 10 positions representing about 80% of assets. Leading holdings include Walmart (about 16–17%), Costco Wholesale (about 14%), Procter & Gamble (about 11–12%), Coca-Cola (about 10–11%), Philip Morris International (about 9–10%), PepsiCo, Altria Group, Mondelez International, Target, and Colgate-Palmolive. The portfolio is essentially 100% consumer staples, with a net expense ratio of 0.15% (0.25% gross). Launched in July 2025, GXPS remains a younger, smaller fund, which contributes to thinner trading liquidity relative to older peers.

iShares U.S. Consumer Staples ETF (IYK) Overview

IYK is a passively managed fund that seeks to track the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, a benchmark of U.S. consumer staples equities that applies concentration caps (22.5% per issuer and 45% for the largest five names combined) to limit single-stock risk. The fund is non-diversified and was launched in June 2000, giving it a track record spanning more than two decades.

IYK holds roughly 54–58 securities, with its top 10 positions at about 66% of assets. Top holdings include Procter & Gamble (about 13.5%), Coca-Cola (about 12–13%), Philip Morris International (about 11%), PepsiCo (about 7–8%), plus CVS Health, McKesson, Altria Group, Mondelez International, Colgate-Palmolive, and Monster Beverage. Unlike GXPS, IYK's exposure is not purely staples: roughly 82–85% sits in consumer staples, about 11% in healthcare, and a small slice in materials. Its expense ratio is approximately 0.38%.

Industry and Thematic Backdrop

Both funds operate within the consumer staples sector, which investors often treat as a defensive anchor during periods of slowing growth or elevated market volatility. Demand for essential goods tends to hold up in downturns, but the sector's performance is increasingly driven by company-specific execution rather than pure economic cycles. Key catalysts include grocery and warehouse retail share gains, pricing power amid input-cost inflation, the resilience of tobacco and beverage cash flows, and shifts in consumer spending toward value. At the same time, staples face headwinds from volume pressure, currency translation, and, for the tobacco-heavy names, ongoing regulatory scrutiny. The sector's relatively low beta also makes it sensitive to interest-rate expectations, as yield-oriented investors rotate between staples and other income-producing assets.

Performance and Positioning Comparison

In recent weeks and over recent market cycles, the two funds have diverged mainly on concentration and composition. GXPS's uncapped weighting has amplified exposure to Walmart and Costco, two names that have benefited from durable traffic trends and share gains, lending GXPS a momentum tilt. IYK, by contrast, spreads weight more evenly and includes healthcare distributors such as McKesson and CVS Health, whose fortunes are tied to pharmacy and insurance dynamics rather than consumer goods alone.

Relative positioning also differs on volatility. IYK has historically displayed a beta around 0.4–0.5 and a long record of steadier, lower-drawdown behavior, supported by its capped, more diversified basket. GXPS's heavier megacap concentration can magnify both upside and downside swings. On cost, GXPS's roughly 0.15% expense ratio represents a persistent head-start versus IYK's near-0.38% fee, a gap that compounds over multi-year holding periods. Liquidity, however, favors IYK, whose larger asset base and longer trading history support tighter spreads and greater ease of entry and exit.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to see how AI-driven filtering can sharpen your ETF comparison and relative positioning research.

Tickeron AI Verdict

Weighing observable factors, Tickeron's AI would likely favor GXPS at this juncture. The fund's materially lower expense ratio, purer consumer staples exposure, and uncapped concentration in the sector's stronger momentum names give it a structural and tactical edge over IYK. IYK's advantages—greater diversification, lower beta, and superior liquidity—are meaningful but are partially offset by its higher fee and its exposure to healthcare names that dilute the pure staples thesis. This verdict is probabilistic: if an investor prioritizes stability, depth of history, and trading efficiency, IYK remains a credible alternative, whereas GXPS better suits those seeking concentrated, cost-efficient sector exposure.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations